Genetic Technologies Limited
GNTLF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -91.4% | 21.2% | -12.7% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 100% | 58.3% | -50% | -27% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -321.6% | -110.5% | -51.6% | -131.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -987.2% | -116.6% | -162.2% | -138.8% |
| EPS Diluted | -0.021 | -0.038 | -0.053 | -0.065 |
| % Growth | 43.6% | 29.2% | 18.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |